These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8383887)

  • 1. Apoptosis of S-phase HL-60 cells induced by DNA topoisomerase inhibitors: detection of DNA strand breaks by flow cytometry using the in situ nick translation assay.
    Gorczyca W; Melamed MR; Darzynkiewicz Z
    Toxicol Lett; 1993 Apr; 67(1-3):249-58. PubMed ID: 8383887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays.
    Gorczyca W; Gong J; Darzynkiewicz Z
    Cancer Res; 1993 Apr; 53(8):1945-51. PubMed ID: 8467513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells.
    Del Bino G; Skierski JS; Darzynkiewicz Z
    Exp Cell Res; 1991 Aug; 195(2):485-91. PubMed ID: 1649059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation.
    Del Bino G; Bruno S; Yi PN; Darzynkiewicz Z
    Cell Prolif; 1992 Nov; 25(6):537-48. PubMed ID: 1333822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
    Bertrand R; Solary E; Jenkins J; Pommier Y
    Exp Cell Res; 1993 Aug; 207(2):388-97. PubMed ID: 7688316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.
    Gorczyca W; Gong J; Ardelt B; Traganos F; Darzynkiewicz Z
    Cancer Res; 1993 Jul; 53(13):3186-92. PubMed ID: 8319228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric detection of apoptosis: comparison of the assays of in situ DNA degradation and chromatin changes.
    Hotz MA; Gong J; Traganos F; Darzynkiewicz Z
    Cytometry; 1994 Mar; 15(3):237-44. PubMed ID: 8187583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features of apoptotic cells measured by flow cytometry.
    Darzynkiewicz Z; Bruno S; Del Bino G; Gorczyca W; Hotz MA; Lassota P; Traganos F
    Cytometry; 1992; 13(8):795-808. PubMed ID: 1333943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Camptothecin, teniposide, or 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells.
    Del Bino G; Darzynkiewicz Z
    Cancer Res; 1991 Feb; 51(4):1165-9. PubMed ID: 1997159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different modes of cell-killing action between DNA topoisomerase I and II inhibitors revealed by kinetic analysis.
    Inaba M; Mitsuhashi J; Kawada S; Nakano H
    Jpn J Cancer Res; 1994 Feb; 85(2):187-93. PubMed ID: 8144400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.
    Ellis AL; Nowak B; Plunkett W; Zwelling LA
    Cancer Chemother Pharmacol; 1994; 34(3):249-56. PubMed ID: 8004759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of topoisomerase inhibitor-induced DNA strand breakage and cytotoxicity by tumor necrosis factor: enhancement of topoisomerase activity as a mechanism of potentiation.
    Utsugi T; Mattern MR; Mirabelli CK; Hanna N
    Cancer Res; 1990 May; 50(9):2636-40. PubMed ID: 2158396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
    Ling YH; Andersson BS; Nelson JA
    Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity of inhibitors of DNA topoisomerases I (camptothecin) and II (m-AMSA) in vivo and in vitro.
    Backer LC; Allen JW; Harrington-Brock K; Campbell JA; DeMarini DM; Doerr CL; Howard DR; Kligerman AD; Moore MM
    Mutagenesis; 1990 Nov; 5(6):541-7. PubMed ID: 2175833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.
    Kaufmann WK; Boyer JC; Estabrooks LL; Wilson SJ
    Mol Cell Biol; 1991 Jul; 11(7):3711-8. PubMed ID: 1646393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells.
    Hotz MA; Del Bino G; Lassota P; Traganos F; Darzynkiewicz Z
    Cancer Res; 1992 Mar; 52(6):1530-5. PubMed ID: 1540962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase.
    Lefevre D; Riou JF; Ahomadegbe JC; Zhou DY; Benard J; Riou G
    Biochem Pharmacol; 1991 Jun; 41(12):1967-79. PubMed ID: 1645555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous analysis of DNA replication and apoptosis during treatment of HL-60 cells with camptothecin and hyperthermia and mitogen stimulation of human lymphocytes.
    Li X; Traganos F; Darzynkiewicz Z
    Cancer Res; 1994 Aug; 54(16):4289-93. PubMed ID: 8044773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors.
    Solary E; Bertrand R; Kohn KW; Pommier Y
    Blood; 1993 Mar; 81(5):1359-68. PubMed ID: 8382972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay.
    Godard T; Deslandes E; Sichel F; Poul JM; Gauduchon P
    Mutat Res; 2002 Sep; 520(1-2):47-56. PubMed ID: 12297143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.